4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-043340
Chief Financial Officer sold 3,000 shares at $9.17 ($27,510)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2023-07-24 | Sale 10b5-1 | +3,000 | $9.17 | $27,510 | 101,768 | D |
| Open-market sales · 3,000 sh · avg $9.17 · $27,510 | |||||||
Loading xslF345X05/doc4.xml…